Evidence map›Paper›PMID 34959408›Full record

ReviewPharmaceutics2021

Polymeric Materials for Hemostatic Wound Healing.

Suvash Ghimire, Pritha Sarkar, Kasey Rigby, Aditya Maan, Santanu Mukherjee, Kaitlyn E Crawford, Kausik Mukhopadhyay

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Suvash GhimireDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Pritha SarkarDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Kasey RigbyDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Aditya MaanDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Santanu MukherjeeDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Kaitlyn E CrawfordDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.
Kausik MukhopadhyayDepartment of Materials Science and Engineering, University of Central Florida, Orlando, FL 32816, USA.ORCID 0000-0001-9526-3791
University of Central Florida · US

Funding

University of Central Florida Office of Undergraduate Research and College of Graduate Studies
6 · The paper itself

Abstract

Hemorrhage is one of the greatest threats to life on the battlefield, accounting for 50% of total deaths. Nearly 86% of combat deaths occur within the first 30 min after wounding. While external wound injuries can be treated mostly using visual inspection, abdominal or internal hemorrhages are more challenging to treat with regular hemostatic dressings because of deep wounds and points of injury that cannot be located properly. The need to treat trauma wounds from limbs, abdomen, liver, stomach, colon, spleen, arterial, venous, and/or parenchymal hemorrhage accompanied by severe bleeding requires an immediate solution that the first responders can apply to reduce rapid exsanguinations from external wounds, including in military operations. This necessitates the development of a unique, easy-to-use, FDA-approved hemostatic treatment that can deliver the agent in less than 30 s and stop bleeding within the first 1 to 2 min at the point of injury without application of manual pressure on the wounded area.

Indexed as

bloodhemostasishydrogelsmetalsnanoparticlespolymerwound

Identifiers

PMID34959408
PMCPMC8708336
OpenAlexW4200251915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.